COM:PHIOPHARMA
Phio Pharmaceuticals
- Stock
Last Close
2.53
22/11 21:00
Market Cap
2.61M
Beta: -
Volume Today
14.85K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 399K - | 71K 82.21% | 34K 52.11% | 19K 44.12% | 15K 21.05% | 138K 820.00% | 21K 84.78% | |||||
cost of revenue | 126K - | |||||||||||
gross profit | 399K - | 71K 82.21% | 34K 52.11% | 19K 44.12% | 15K 21.05% | 138K 820.00% | 21K 84.78% | -126K - | ||||
selling and marketing expenses | ||||||||||||
general and administrative expenses | 3.70M - | 3.22M 12.98% | 3.35M 4.01% | 3.62M 8.16% | 4.01M 10.83% | 3.18M 20.82% | 4.71M 48.24% | 4.36M 7.35% | 4.63M 6.03% | 4.45M 3.78% | 4.37M 1.89% | |
selling general and administrative expenses | 3.70M - | 3.22M 12.98% | 3.35M 4.01% | 3.62M 8.16% | 4.01M 10.83% | 3.18M 20.82% | 4.71M 48.24% | 4.36M 7.35% | 4.63M 6.03% | 4.45M 3.78% | 4.37M 1.89% | |
research and development expenses | 17.65M - | 5.68M 67.82% | 6.92M 21.92% | 5.42M 21.81% | 5.37M 0.83% | 4.33M 19.44% | 4.30M 0.60% | 4.43M 3.05% | 8.89M 100.54% | 7.01M 21.09% | 6.33M 9.70% | |
other expenses | 2.63M - | 2.21M 16.08% | 2.44M 10.69% | 3.11M 27.14% | 4.70M 51.19% | 4K 99.91% | 79K 1,875% | -1K 101.27% | 224K 22,500% | -18K 108.04% | ||
cost and expenses | 21.35M - | 8.90M 58.32% | 10.27M 15.44% | 9.03M 12.04% | 9.38M 3.84% | 7.50M 20.03% | 9.01M 20.07% | 8.79M 2.39% | 13.51M 53.66% | 11.46M 15.17% | 10.82M 5.57% | |
operating expenses | 21.35M - | 8.90M 58.32% | 10.27M 15.44% | 9.03M 12.04% | 9.38M 3.84% | 7.50M 20.03% | 9.01M 20.07% | 8.79M 2.39% | 13.51M 53.66% | 11.46M 15.17% | 10.70M 6.67% | |
interest expense | 24K - | -1K - | -9K - | -175K 1,844.44% | ||||||||
ebitda | -20.85M - | -8.84M 57.63% | -10.23M 15.85% | -9.04M 11.71% | -4.66M 48.44% | -7.36M 58.06% | -8.99M 22.04% | -8.72M 2.96% | -13.51M 54.92% | -11.46M 15.17% | -10.82M 5.57% | |
operating income | -20.95M - | -8.83M 57.87% | -10.24M 15.99% | -9.02M 11.94% | -14.06M 55.98% | -7.36M 47.63% | -8.99M 22.04% | -8.79M 2.16% | -13.51M 53.66% | -11.46M 15.17% | -10.82M 5.57% | |
depreciation and amortization | 99K - | 87K 12.12% | 77K 11.49% | 53K 31.17% | 70K 32.08% | 81K 15.71% | 67K 17.28% | 72K 7.46% | 75K 4.17% | 193K 157.33% | ||
total other income expenses net | 24K - | 9K 62.50% | -2K 122.22% | 21K 1,150% | -4.71M 22,514.29% | 4K 100.08% | 79K 1,875% | -1K 101.27% | 224K 22,500% | -18K 108.04% | -2K 88.89% | |
income before tax | -20.93M - | -8.80M 57.95% | -10.22M 16.17% | -8.99M 12.02% | -14.07M 56.47% | -7.36M 47.70% | -8.91M 21.03% | -8.79M 1.28% | -13.29M 51.09% | -11.48M 13.60% | -10.83M 5.70% | |
income tax expense | -113K - | -91K 19.47% | -74K 18.68% | -1.62M 2,090.54% | 4K 100.25% | -67K 1,775% | -75K - | -175K 133.33% | ||||
net income | -20.93M - | -8.80M 57.95% | -10.22M 16.17% | -8.99M 12.02% | -12.45M 38.45% | -7.36M 40.89% | -8.84M 20.12% | -8.79M 0.53% | -13.21M 50.24% | -11.30M 14.43% | -10.83M 4.24% | |
weighted average shs out | 178 - | 333 87.08% | 990 197.30% | 1.02K 3.23% | 3.42K 234.64% | 10.66K 211.78% | 38.40K 260.12% | 382.28K 895.52% | 1.07M 179.81% | 1.14M 6.25% | 2.08B 183,221.43% | |
weighted average shs out dil | 178 - | 333 87.08% | 990 197.30% | 1.02K 3.23% | 3.42K 234.64% | 10.66K 211.78% | 38.40K 260.12% | 382.28K 895.52% | 1.07M 179.81% | 1.14M 6.25% | 2.08B 183,221.43% | |
eps | -117.56K - | -26.43K 77.52% | -10.33K 60.92% | -8.80K 14.78% | -3.64K 58.63% | -690.24 81.04% | -230.23 66.64% | -23 90.01% | -12.35 46.30% | -9.95 19.43% | -0.01 99.95% | |
epsdiluted | -117.56K - | -26.43K 77.52% | -10.33K 60.92% | -8.80K 14.78% | -3.64K 58.63% | -690.24 81.04% | -230.23 66.64% | -23 90.01% | -12.35 46.30% | -9.95 19.43% | -0.01 99.95% |
All numbers in (except ratios and percentages)